Abensia Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
- Revenue Growth 3.39%
- Profit Growth 9.89%
- Ebitda 9.83%
- Net Worth 472.76%
- Total Assets 7.07%
About Abensia Healthcare
Abensia Healthcare Private Limited (AHPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 2013 and has a history of 11 years and 11 months. Its registered office is in Guwahati, Assam, India.
The Corporate was formerly known as Apollon Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.20 M.
Debalina Deb and Subhendu Debroy serve as directors at the Company.
Company Details
- Location
Guwahati, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230AS2013PTC011436
- Company No.
011436
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Abensia Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debalina Deb  | Director | 01-Nov-2018 | Current |
| Subhendu Debroy | Director | 06-Mar-2013 | Current |
Financial Performance of Abensia Healthcare.
Abensia Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.39% increase. The company also saw a slight improvement in profitability, with a 9.89% increase in profit. The company's net worth Soared by an impressive increase of 472.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abensia Healthcare?
In 2023, Abensia Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2015 | Others | ₹1.20 M | Open |
How Many Employees Work at Abensia Healthcare?
Unlock and access historical data on people associated with Abensia Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abensia Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abensia Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
